Home/Diverse Biotech/Philip Arlen, PhD
PA

Philip Arlen, PhD

Chief Scientific Officer

Diverse Biotech

Therapeutic Areas

Diverse Biotech Pipeline

DrugIndicationPhase
Conjugate Platform for GlioblastomaGlioblastomaPre-clinical